Literature DB >> 19735071

A note on the power prior.

Beat Neuenschwander1, Michael Branson, David J Spiegelhalter.   

Abstract

The power prior by Ibrahim and Chen (Statist. Sci. 2000; 15:46-60) is one of several methods to incorporate historical data in the analysis of a clinical trial. The power prior raises the likelihood of the historical data to the power parameter a(0) which quantifies the discounting of the historical data due to heterogeneity between trials. It is shown that the standard method of estimating the power parameter from the historical and current data is inappropriate, and we therefore suggest to use a modified power prior approach or to consider alternative methods instead. Copyright (c) 2009 John Wiley & Sons, Ltd.

Mesh：

Year:  2009        PMID： 19735071     DOI： 10.1002/sim.3722

Source DB:  PubMed          Journal:  Stat Med        ISSN： 0277-6715            Impact factor:   2.373


  25 in total

1.  CRM2DIM: A SAS macro for implementing the dual-agent Bayesian continual reassessment method.

Authors:  Mohamed Amine Bayar; Anastasia Ivanova; Gwénaël Le Teuff
Journal:  Comput Methods Programs Biomed       Date:  2019-05-06       Impact factor: 5.428

2.  Bayesian design of noninferiority trials for medical devices using historical data.

Authors:  Ming-Hui Chen; Joseph G Ibrahim; Peter Lam; Alan Yu; Yuanye Zhang
Journal:  Biometrics       Date:  2011-03-01       Impact factor: 2.571

3.  Hierarchical commensurate and power prior models for adaptive incorporation of historical information in clinical trials.

Authors:  Brian P Hobbs; Bradley P Carlin; Sumithra J Mandrekar; Daniel J Sargent
Journal:  Biometrics       Date:  2011-03-01       Impact factor: 2.571

4.  Joining and splitting models with Markov melding.

Authors:  Robert J B Goudie; Anne M Presanis; David Lunn; Daniela De Angelis; Lorenz Wernisch
Journal:  Bayesian Anal       Date:  2019-01       Impact factor: 3.728

5.  Modeling and validating Bayesian accrual models on clinical data and simulations using adaptive priors.

Authors:  Yu Jiang; Steve Simon; Matthew S Mayo; Byron J Gajewski
Journal:  Stat Med       Date:  2014-11-06       Impact factor: 2.373

6.  Commensurate Priors on a Finite Mixture Model for Incorporating Repository Data in Clinical Trials.

Authors:  Byron J Gajewski; C Shane Reese; John Colombo; Susan E Carlson
Journal:  Stat Biopharm Res       Date:  2016-06-02       Impact factor: 1.452

Review 7.  Use of historical control data for assessing treatment effects in clinical trials.

Authors:  Kert Viele; Scott Berry; Beat Neuenschwander; Billy Amzal; Fang Chen; Nathan Enas; Brian Hobbs; Joseph G Ibrahim; Nelson Kinnersley; Stacy Lindborg; Sandrine Micallef; Satrajit Roychoudhury; Laura Thompson
Journal:  Pharm Stat       Date:  2013-08-05       Impact factor: 1.894

8.  A Calibrated Power Prior Approach to Borrow Information from Historical Data with Application to Biosimilar Clinical Trials.

Authors:  Haitao Pan; Ying Yuan; Jielai Xia
Journal:  J R Stat Soc Ser C Appl Stat       Date:  2016-12-23       Impact factor: 1.864

9.  The use of local and nonlocal priors in Bayesian test-based monitoring for single-arm phase II clinical trials.

Authors:  Yanhong Zhou; Ruitao Lin; J Jack Lee
Journal:  Pharm Stat       Date:  2021-05-19       Impact factor: 1.234

10.  The influence of baseline marijuana use on treatment of cocaine dependence: application of an informative-priors bayesian approach.

Authors:  Charles Green; Joy Schmitz; Jan Lindsay; Claudia Pedroza; Scott Lane; Rob Agnelli; Kimberley Kjome; F Gerard Moeller
Journal:  Front Psychiatry       Date:  2012-10-30       Impact factor: 4.157
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.